This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Genpact's CEO Discusses Q1 2012 Results - Earnings Call Transcript

With consistent implementation and investment, we are winning client engagements and creating a clearly differentiated business model that will help drive sustainable growth beyond 2012. The five key elements of this growth strategy are, first, guide global enterprises to best-in-class through our proprietary Smart Enterprise Process framework that delivers improved outcome for them.

Second, investors and those started at vertical industry and horizontal domain expertise. Third, combined data analytics and process expertise to create meaningful insights. Fourth, expand geographically in terms of both market and delivery capability. And finally, add new capabilities through acquisitions. I will now discuss these elements and give examples of how they work for us this quarter. First, guiding the enterprise to best-in-class through our proprietary SEP framework.

Our clients get focused on adjusting their business and operations to the new normal, they tell us that they’re looking for partners who can help them with a number of challenges, including migrating their businesses to a more valuable cost structure, seeking innovative solutions to help them balance the challenges of lower growth in developed economies and capturing higher growth in emerging markets, and driving a comprehensive agenda of transformation to achieve all of this.

In each of these cases, the key differentiator is delivering better outcomes and effectiveness not just in the services we manage for the client, but across the clients entire delivery footprint. All this leads to deeper client relationships over time and a much bigger impact for them.

As an example, in the first quarter, we established a new client relationship with a large global pharma major, based on our demonstrated expertise and differentiated approach in improving effectiveness and delivering outcomes. We use SEP to build a roadmap to take them on a journey to best-in-class, including assessing the health of their finance and procurement processes globally, and building an operating platform to support future rapid growth.

Based on our extensive knowledge of the pharma industry and process expertise, during the assessment phase we were able to significantly expand the engagement into running the full range of finance and procurement processes.

Read the rest of this transcript for free on

3 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,813.39 +1.20 0.01%
S&P 500 2,088.87 -0.27 -0.01%
NASDAQ 5,116.1430 +13.3350 0.26%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs